CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
Open Access
- 10 July 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 4930
Abstract
Gastric cancer is the third most common cause of cancer mortality, and the survival rate of stage IV advanced gastric cancer (AGC) patients with distant metastasis is very low. Thus, the detection and eradication of disseminated cancer cells by targeting cell surface molecules in AGC would improve patient survival. The hyaluronic acid receptor, CD44, has various isoforms generated by alternative splicing, and some isoforms are known to be correlated to gastric cancer. In this study, to find out the most appropriate CD44v for targeting AGC, we analysed the expression differences of CD44 isoforms at the mRNA level in stomach cancer cell lines as well as in 74 patients with AGC by using exon-specific qRT-PCR. Among the CD44v isoforms, CD44v8-10 was determined as the most promising biomarker for the development of theranostic agents of gastric cancer. Next, we synthesised the conjugate of anti-CD44v9 antibody with near-infrared fluorophore or photosensitiser, and then demonstrated its feasibility for target cell-specific imaging and photoimmunotherapy in gastric cancer. As a result, these conjugates have clearly demarcated the surface of CD44v8-10 expressing cancer cells and showed efficient phototoxic effects. Therefore, this study revealed that CD44v8-10 is the efficient theranostic biomarker to target disseminated cancer cells in AGC.Keywords
This publication has 38 references indexed in Scilit:
- Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progressionMolecular Cancer, 2012
- Hyaluronan–CD44 interactions as potential targets for cancer therapyThe FEBS Journal, 2011
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialInternational Journal of Cancer, 2010
- Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blueSurgery, 2010
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- CD44 in CancerCritical Reviews in Clinical Laboratory Sciences, 2002
- Silencing of the CD44 Gene by CpG Methylation in a Human Gastric Carcinoma Cell LineJapanese Journal of Cancer Research, 1999
- CD44H Plays an Important Role in Peritoneal Dissemination of Scirrhous Gastric Cancer CellsJapanese Journal of Cancer Research, 1996